Mountain Capital Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,830
Closed -$851K 64
2023
Q4
$851K Buy
9,830
+1,569
+19% +$120K 0.29% 28
2023
Q3
$584K Sell
8,261
-832
-9% -$69.6K 0.22% 38
2023
Q2
$807K Buy
+9,093
New +$783K 0.3% 47
2021
Q2
Sell
-7,107
Closed -$879K 136
2021
Q1
$879K Buy
7,107
+4,070
+134% +$477K 0.44% 90
2020
Q4
$360K Buy
3,037
+344
+13% +$37.9K 0.22% 115
2020
Q3
$294K Buy
+2,693
New +$270K 0.19% 89

Other funds holding MDT

Mountain Capital Investment Advisors's MDT Position: Q1 2024 in Review

Mountain Capital Investment Advisors sold out of Medtronic (MDT) in Q1 2024, closing a stake of 9,830 shares — an estimated $851K sold.

Mountain Capital Investment Advisors first reported a position in MDT in Q3 2020 and held it in 6 quarters. The position peaked at $879K in Q1 2021. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Mountain Capital Investment Advisors reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 9,830 Medtronic shares in Q1 2024, an estimated $851K.
  • Mountain Capital Investment Advisors first reported a position in Medtronic in Q3 2020 and held it in 6 quarters.
  • Mountain Capital Investment Advisors's Medtronic position peaked at $879K in Q1 2021.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Mountain Capital Investment Advisors's 13F filing for Q1 2024, filed 11 Apr 2024.